Dr Paul Gallagher (Institute of Neurological Sciences, Glasgow, UK) provides an overview of these two recent papers by Jokubaitis and colleagues  and Cree and colleagues, which both assessed factors predictive of long-term disability outcomes in people with multiple sclerosis (MS).
Take a look at our infographic – we explore our current knowledge of the interactions between alcohol and epigenetic mechanisms, and take a look at the latest research and drug targets.
David Howett reviews a recent paper from Hefendehl et al. that reported that the microenvironment surrounding amyloid plaques disrupts neuronal glutamate homeostasis
Lauren Pulling highlights some of the key trending topics in neurology and neuroscience from 2016, as well as the top read articles of the year – take a look and let us know your thoughts.
Journal Watch columnist David Howett reviews the recent paper ‘Complement biomarkers as predictors of disease progression in Alzheimer’s disease’ and what its findings could mean for the future of Alzheimer’s disease diagnostics.
David Burn, Clinical Director of Parkinson’s UK, discusses the results of the 2015 UK Parkinson’s Audit, which concerns the quality of Parkinson’s disease care provided in the UK.
A comprehensive series of reviews, data and reports discussing how researchers may utilize the visual system to further understand the progression of MS has been presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress.